| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1659301-59-3 | Rosuvastatin Impurity 3;(R,2Z,6E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-5-hydroxyhepta-2,6-dienoic acid, sodium salt | C22H25FN3O5S .Na |
| 1660143-42-9 | Carfilzomib Impurity 8;(2S)-N-((2S)-1-(((4R)-2,6-dimethyl-3-oxohept-1-en-4-yl)amino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-(((2S)-2-((2-morpholin-4-ylacetyl)amino)-4-phenylbutanoyl)amino)pentanamide | C40H57N5O6 |
| 1660153-91-2 | 2'-((1,1-Dimethylethyl)phenylphosphino)-N2,N2,N6,N6-tetramethyl-(1,1'-biphenyl)-2,6-diamine;2-(2-(tert-butyl(phenyl)phosphanyl)phenyl)-1-N,1-N,3-N,3-N-tetramethylbenzene-1,3-diamine | C26H33N2P |
| 1660957-93-6 | Bromhexine EP Impurity E Chloride;(3RS)-6,8-Dibromo-3-cyclohexyl-3-methyl-1,2,3,4-tetrahydroquinazolin-3-ium Chloride | C15H21Br2ClN2 |
| 1660963-42-7 | N-(3-(2-((2,3-Difluoro-4-(4-(2-hydroxyethyl)piperazin-1-yl)phenyl)amino)quinazolin-8-yl)phenyl)acrylamide | C29H28F2N6O2 |
| 1661042-31-4 | (t-Bu)PhCPhos Pd G3;(2'-(Amino-?N)(1,1'-biphenyl)-2-yl-?C)(2'-((1,1-dimethylethyl)phenylphosphino-?P)-N2,N2,N6,N6-tetramethyl(1,1'-biphenyl)-2,6-diamine)(methanesulfonato-?O)palladium | C39H47N3O3PPdS- |
| 1661839-45-7 | 8-(3-Chloro-5-(4-(1-methyl-1H-pyrazol-4-yl)phenyl)-4-pyridinyl)-2,8-diazaspiro(4.5)decan-1-one;CCT 251545 | C23H24ClN5O |
| 1661854-97-2 | (S)-N-(4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido(5,4-b)indolizin-8-yl)acrylamide;N-((8S)-4-amino-6-methyl-5-quinolin-3-yl-8,9-dihydropyrimido(5,4-b)indolizin-8-yl)prop-2-enamide | C23H20N6O |
| 1662688-20-1 | Fmoc-L-Lys(Oct-(otBu)-Glu-(otBu)-AEEA-AEEA)-OH;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-((2-(2-(2-((2-(2-(2-(((4S)-5-((2-methylpropan-2-yl)oxy)-4-((18-((2-methylpropan-2-yl)oxy)-18-oxooctadecanoyl)amino)-5-oxopentanoyl)amino)ethoxy)ethoxy)acetyl)amino)ethoxy)ethoxy)acetyl)amino)hexanoic acid | C64H101N5O16 |
| 1662702-90-0 | Dapagliflozin Impurity B;1-Chloro-2-(4-ethoxybenzyl)benzene | C15H15ClO |
| 1665195-94-7 | 4-(4-(1-Methyl-1H-pyrazol-4-yl)-1-(2-(1-methyl-1H-pyrazol-4-yl)ethyl)-1H-imidazol-5-yl)benzonitrile | C20H19N7 |
| 1665288-66-3 | 6-Fluoro-4-benzothiazolol | C7H4FNOS |
| 1668553-26-1 | 7-(5-((4-(4-((Dimethylamino)sulfonyl)-1-piperazinyl)phenoxy)methyl)-1,3-dimethyl-1H-pyrazol-4-yl)-1-(2-(4-morpholinyl)ethyl)-3-(3-(1-naphthalenyloxy)propyl)-1H-indole-2-carboxylic acid | C46H55N7O7S |
| 1672665-29-0 | 4-Fluoro-7-(methylsulfonyl)-2,3-dihydro-1H-inden-1-one;4-Fluoro-7-(methylsulfonyl)-1-indanone | C10H9FO3S |
| 1672665-55-2 | 3-Fluoro-5-((7-(methylsulfonyl)-1-oxo-2,3-dihydro-1H-inden-4-yl)oxy)benzonitrile | C17H12FNO4S |
| 1672665-69-8 | 3-Fluoro-5-((7-(methylthio)-1-oxo-2,3-dihydro-1H-inden-4-yl)oxy)benzonitrile | C17H12FNO2S |
| 1672668-24-4 | Belzutifan;3-(((1S,2S,3R)-2,3-difluoro-1-hydroxy-7-methylsulfonyl-2,3-dihydro-1H-inden-4-yl)oxy)-5-fluorobenzonitrile | C17H12F3NO4S |
| 1672668-41-5 | 3-Fluoro-5-((7-(methylsulfonyl)-3-oxo-2,3-dihydrospiro(indene-1,2'-(1,3)dioxolan)-4-YL)oxy)benzonitrile | C19H14FNO6S |
| 1672698-96-2 | Carfilzomib Impurity 4;N-Oxide Impurity; 4-({((1S)-1-{((1S)-3-methyl-1-{((1S)-1-{((2R)-4-methyl-1-((2R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)carbamoyl}-2-phenylethyl)carbamoyl}butyl)carbamoyl}-3-phenylpropyl)carbamoyl}methyl)morpholin-4-ium-4-olate | C40H57N5O8 |
| 1673560-66-1 | PD-1-IN-17;(2S)-2-(((1S)-4-amino-1-(5-((1S,2R)-1-amino-2-hydroxypropyl)-1,3,4-oxadiazol-2-yl)-4-oxobutyl)carbamoylamino)-3-hydroxypropanoic acid | C13H22N6O7 |
| 1674334-59-8 | 3-Bromo-11,11-dimethyl-11H-benzo(b)fluorene | C19H15Br |
| 1675201-14-5 | 1-(5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo(4,3-a)pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)-3-buten-1-one | C16H12F6N4O |
| 1675201-83-8 | (2S)-1-((2,6-Dimethoxy-4-((2-methyl(1,1'-biphenyl)-3-yl)methoxy)phenyl)methyl)-2-piperidinecarboxylic acid | C29H33NO5 |
| 1675203-84-5 | N-(2-(((2-Methoxy-6-((2-methyl(1,1'-biphenyl)-3-yl)methoxy)-3-pyridinyl)methyl)amino)ethyl)acetamide | C25H29N3O3 |
| 1675221-59-6 | Azilsartan Impurity P;2-(4-((2-ethoxy-7-methoxycarbonylbenzimidazol-1-yl)methyl)phenyl)benzoic acid | C25H22N2O5 |
| 1675248-19-7 | (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo(2,3-d)pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanamide | C16H22N6O2 |
| 1676104-73-6 | (4S,5R)-3-((2S,3R)-3-(1,1-Dimethylethoxy)-2-(((9H-fluoren-9-ylmethoxy)carbonyl)amino)-1-oxobutyl)-2,2,5-trimethyl-4-oxazolidinecarboxylicacid | C30H38N2O7 |
| 1676893-24-5 | 2,4-Difluoro-N-(2-methoxy-5-(4-(3-(4-(methylsulfonyl)-1-piperazinyl)-1-propyn-1-yl)-6-quinolinyl)-3-pyridinyl)benzenesulfonamide | C29H27F2N5O5S2 |
| 1677681-05-8 | 1-Benzo(b)thien-4-ylpiperazine hydrochloride (1:2) | C12H14N2S.2(HCl) |
| 1680191-38-1 | 2-Chloro-5-benzothiazolecarboxylic acid ethyl ester | C10H8ClNO2S |
| 1684452-84-3 | Mirabegron Impurity 34;(R)-2-(2-(2-aminothiazol-4-yl)-N-(4-(2-(2-aminothiazol-4-yl)acetamido)phenethyl)acetamido)-1-phenylethyl 2-(2-aminothiazol-4-yl)acetate | C31H32N8O4S3 |
| 1684453-05-1 | Mirabegron Impurity B;(2R)-N-(2-(4-{((2-Amino-1,3-thiazol-4-yl)acetyl)amino}phenyl)ethyl)-2-hydroxy-2-phenylacetamide | C21H22N4O3S |
| 1686100-04-8 | 9-(Biphenyl-4-yl)carbazole-2-boronic acid;B-(9-(1,1'-Biphenyl)-4-yl-9H-carbazol-2-yl)boronic acid | C24H18BNO2 |
| 1686102-84-0 | 4-(4-(Trifluoromethoxy)phenoxy)benzenemethanol;4-(4-(Trifluoromethoxy)phenoxy)benzyl alcohol | C14H11F3O3 |
| 1686124-74-2 | ((3aR,4R,6R,6aR)-6-(4-Amino-2-oxopyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro(3,4-d)(1,3)dioxol-4-yl)methyl Isobutyrate;(4-(4-amino-2-oxopyrimidin-1-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro(3,4-d)(1,3)dioxol-6-yl)methyl 2-methylpropanoate | C16H23N3O6 |
| 1686149-74-5 | 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-(5-methyl-2-oxo-1-piperidinyl)phenyl)-7-oxo-1H-pyrazolo(3,4-c)pyridine-3-carboxamide | C26H27N5O4 |
| 1687736-54-4 | N-6-Isoquinolinyl-N'-(2-oxo-2-(1-pyrrolidinyl)ethyl)urea | C16H18N4O2 |
| 1689542-67-3 | 1-(Phenylsulfonyl)-L-prolyl-4-((5-((aminoiminomethyl)amino)-1-oxopentyl)amino)-L-phenylalanine hydrochloride (1:1) | C26H34N6O6S.HCl |
| 1689576-03-1 | 2-((1,1'-Biphenyl)-3-yl)-4-chloro-6-phenyl-1,3,5-triazine;2-chloro-4-phenyl-6-(3-phenylphenyl)-1,3,5-triazine | C21H14ClN3 |
| 1691249-45-2 | Zanubrutinib;(7S)-2-(4-phenoxyphenyl)-7-(1-prop-2-enoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide | C27H29N5O3 |
| 1693758-51-8 | 2-Amino-N-((1S)-1-(1,2-dihydro-8-(2-(1-methyl-1H-pyrazol-4-yl)ethynyl)-1-oxo-2-phenyl-3-isoquinolinyl)ethyl)-pyrazolo(1,5-a)pyrimidine-3-carboxamide;IPI 549 | C30H24N8O2 |
| 1693766-04-9 | 1-(1-(3-Methoxyphenyl)-7-propoxy-3-indolizinyl)ethanone | C20H21NO3 |
| 1694232-96-6 | tert-Butyl (2-(pyridin-3-ylamino)ethyl)carbamate | C12H19N3O2 |
| 1695533-89-1 | 1,5,6,8-Tetrahydro-6-(phenylmethyl)-3-(4-pyridinyl)-7H-pyrazolo(4,3-g)quinazolin-7-one | C21H17N5O |
| 1696392-11-6 | 1-((2'-(Aminocarbonyl)(1,1'-biphenyl)-4-yl)methyl)-2-ethoxy-1H-benzimidazole-7-carboxylic acid | C24H21N3O4 |
| 1696392-12-7 | Azilsartan Impurity Q;(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 3-((4-(2-carbamoylphenyl)phenyl)methyl)-2-ethoxybenzimidazole-4-carboxylate | C29H25N3O7 |
| 1698027-17-6 | 2-Amino-4-bromo-5-chloro-3-fluorobenzoic acid | C7H4BrClFNO2 |
| 1698028-10-2 | 7-Bromo-6-chloro-8-fluoroquinazoline-2,4(1H,3H)-dione | C8H3BrClFN2O2 |
| 1698028-15-7 | Methyl 2-amino-4-bromo-5-chloro-3-fluorobenzoate | C8H6BrClFNO2 |
| 1698293-93-4 | 2-Isopropyl-4-methylpyridin-3-amine | C9H14N2 |